Business
Why the Alterity (ASX:ATH) share price is skyrocketing 42% today
One of the best performers on the ASX today is the Alterity Therapeutics Ltd (ASX: ATH) share price. Driving the meteoric rise, the biotech company announced positive results for its lead compound, ATH434.
At the time of writing, Alterity shares are swapping hands for 4.25 cents apiece, up 41.67%.
What does Alterity do?
Alterity is an Australian biotech company focused on commercialising research into neurodegenerative disorders. These include Parkinsonian movement disorders, Alzheimer’s disease, Huntington disease and others.
The company’s lead candidate ATH434 is currently in development. It aims to block the aggregation of pathological proteins that cause brain degeneration. Current remedies include medications and lifestyle…
-
General19 hours agoSearch underway for missing boat off South Australia’s Cape Jaffa
-
Noosa News19 hours agoQueensland coroner investigates ‘extremely unusual’ deaths of premature twin boys
-
General22 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
Noosa News21 hours agoUpdate: Attempted murder charges, Maroochydore